Tag: emerging treatment
-
Analysis shows Deputax-M is unsuccessful
Deputax-M failed to meet its target overall survival during an interim analysis of a phase 3 clinical trial in glioblastoma
-
Nivolumab fails to meet its target
Nivolumab, an immunotherapy drug, has been unsuccessful in improving overall survival in a phase 3 clinical trial when tested in newly diagnosed glioblastoma with unmethylated MGMT
-
New treatments for diffuse midline gliomas
A new type of drug that targets a particular protein could become the first ever treatment designed for children with diffuse midline gliomas (formerly known as DIPG)
-
A new, non-disruptive brain surgery technology is now being used in London
BrainPath is a surgical technique that uses the brain’s own tissue folds to tract a path to the tumour site. It is designed to be minimally invasive.
-
NHS England to double pioneering form of robotic radiosurgery
The targeted radiotherapy treatment will be offered to more than 6,200 patients a year by 2018/19 as part of NHS England’s Cancer Strategy.
-
Research developments in 2016: what the experts think
A major study has asked medical experts across the University of California, San Francisco, what they see as real developments in the coming year.
-
How the deadly Lassa and Ebola viruses could help destroy brain tumour cells
Deadly viruses are being combined with a cancer cell killing virus in trials aimed at destroying glioma brain tumours.
-
GM algae holds potential breakthrough in treating brain tumours
Australian researchers, coordinating with teams from Germany, have trialled genetically-modified algae loaded with chemotherapy drugs and found that they destroy 90% of cancer cells while leaving healthy ones intact.
-
Canadian scientists develop ‘game-changer’ blood-brain barrier treatment
Claiming to be a world’s first, Canadian scientists have used targeted ultrasound and microbubbles to deliver chemotherapy drugs directly into brain tumours.
-
Our response to the Accelerated Access Review
The interim report of the Accelerated Access Review, a UK Government review looking at ways to speed up patient access to new drugs, was published on the 27th October.
-
Bristol pioneers new development in Gamma Knife radiosurgery
A pioneering development in Gamma Knife radiosurgery treatment of brain tumours is undergoing trials at Bristol Royal Infirmary.